Cargando…
Gambogenic Acid Exerts Antitumor Activity in Hypoxic Multiple Myeloma Cells by Regulation of miR-21
Hypoxia is an inseparable component of the bone marrow (BM) microenvironment, accounting for aggressive tumor behavior and poor prognosis of multiple myeloma (MM). Gambogenic acid (GNA) has proven to be an attractive option for treatment of tumors due to its tumor suppressive activity. Herein, we fo...
Autores principales: | Liu, Ping, Wu, Xue, Dai, Lu, Ge, Zheng, Gao, Chong, Zhang, Hongming, Wang, Fei, Zhang, Xiaoping, Chen, Baoan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665045/ https://www.ncbi.nlm.nih.gov/pubmed/29158801 http://dx.doi.org/10.7150/jca.19290 |
Ejemplares similares
-
Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma
por: Chen, Runzhe, et al.
Publicado: (2017) -
Gambogenic acid exerts anticancer effects in cisplatin-resistant non-small cell lung cancer cells
por: Shen, Daofu, et al.
Publicado: (2020) -
Gambogenic acid inhibits the proliferation of small-cell lung cancer cells by arresting the cell cycle and inducing apoptosis
por: Huang, Tingting, et al.
Publicado: (2019) -
Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin
por: He, Ye, et al.
Publicado: (2015) -
Gambogenic Acid Kills Lung Cancer Cells through Aberrant Autophagy
por: Mei, Wang, et al.
Publicado: (2014)